D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 195,645
- Value
- $2.83M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 195,645 | $2.83M | <0.1% | −274,625−58.4% | Reduced | Holders |
| Q1 2026 | 470,270 | $5.00M | <0.1% | +31,376+7.1% | Added | Holders |
| Q4 2025 | 438,894 | $4.12M | <0.1% | +65,618+17.6% | Added | Holders |
| Q3 2025 | 373,276 | $2.81M | <0.1% | −17,372−4.4% | Reduced | Holders |
| Q2 2025 | 390,648 | $1.32M | <0.1% | −4,603−1.2% | Reduced | Holders |
| Q1 2025 | 395,251 | $1.53M | <0.1% | −117,079−22.9% | Reduced | Holders |
| Q4 2024 | 512,330 | $3.16M | <0.1% | −70,528−12.1% | Reduced | Holders |
| Q3 2024 | 582,858 | $3.14M | <0.1% | +47,074+8.8% | Added | Holders |
| Q2 2024 | 535,784 | $1.79M | <0.1% | +89,594+20.1% | Added | Holders |
| Q1 2024 | 446,190 | $1.80M | <0.1% | +155,562+53.5% | Added | Holders |
| Q4 2023 | 290,628 | $770.2K | <0.1% | +278,888+2,375.5% | Added | Holders |
| Q3 2023 | 11,740 | $27.7K | <0.1% | −123,540−91.3% | Reduced | Holders |
| Q2 2023 | 135,280 | $852.3K | <0.1% | +23,982+21.5% | Added | Holders |
| Q1 2023 | 111,298 | $642.2K | <0.1% | +111,298 | New | Holders |